Hinge Health Lifts Guidance as Client Bases Grow
Employers buying virtual care programs are seeing a vendor expand client counts across several condition areas at once.
Updated on Nov. 3, 2026 in Healthcare
Live Poll
Do you think your household's health care is getting better or worse?
Hinge Health reported third-quarter earnings of 66 cents per share, beating the analyst consensus of 60 cents, and raised its FY2026 sales guidance to $879 million-$881 million. Shares on the New York Stock Exchange rose 1.3% to $117.25 in pre-market trading.
Why it matters
The beat and guidance raise signal that demand for its digital musculoskeletal and other care programs is outpacing expectations, a useful read for operators watching how employers and health plans are buying virtual care. The growth is tied to a technology platform that scales and automates care delivery.
Quarterly sales reached $235.000 million against a $224.561 million analyst consensus, and FY2026 sales guidance was lifted to $879.000 million-$881.000 million from $856.000 million-$860.000 million. Client bases grew roughly 30% year over year for the MSK Care Program, about 40% since the August Cylinder Health acquisition announcement for GI Care, and nearly doubled since the prior quarter for Migraine Care.
The players
Hinge Health
A publicly traded digital health company that delivers virtual musculoskeletal, GI and migraine care programs to employers and health plans, listed on the New York Stock Exchange.
Needham
An investment bank whose research arm issues equity ratings and price targets on publicly traded companies.
Stifel
A financial services firm whose research division issues equity ratings and price targets on publicly traded companies.
Canaccord Genuity
A financial services firm whose research division issues equity ratings and price targets on publicly traded companies.
The details
Hinge Health attributes its growth to a technology platform designed to scale and automate care delivery, which allows it to add client organizations across several program lines. The company announced its acquisition of Cylinder Health in August, and the GI Care client base has since expanded roughly 40%. Analysts at Needham, Stifel and Canaccord Genuity each maintained Buy ratings and raised their price targets, with Needham and Stifel moving to $135 and Canaccord Genuity to $134.
Timeline
August: Hinge Health announced its acquisition of Cylinder Health.
Monday: Hinge Health reported third-quarter earnings results.
Market Landscape
Virtual musculoskeletal care has become one of the more closely watched segments of digital health, and Hinge Health's results add to evidence that employer-sponsored programs are expanding beyond a single condition area. Its move into GI care through the Cylinder Health acquisition shows the company widening its clinical scope rather than relying on one program.
Operators who buy employee health benefits should note that virtual care vendors are expanding their scope across condition areas, which may change how they compare programs at renewal. Businesses evaluating benefit providers should review contract terms and program scope with a qualified benefits advisor before committing.
The takeaway
Hinge Health's guidance raise suggests employer demand for its condition-specific programs is strengthening, so benefits managers may want to track whether competitors report similar client growth. Operators comparing virtual care vendors should request current program-level utilization and client-count data before their next plan renewal.
Further reading
For broader context on how virtual care is reshaping employer health spending, see Healthcare.
Source note: This article includes information reported by Benzinga.
Live Poll
Do you think your household's health care is getting better or worse?
